Press Releases Print Email
All Releases
View Summary VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia
Nov 26, 2014
PDF 12.2 KB Add to Briefcase
View Summary VIVUS Reports Third Quarter 2014 Financial Results
Nov 5, 2014
PDF 32.0 KB Add to Briefcase
View Summary VIVUS Announces Qsymia Presentations at Obesity Week 2014
Nov 3, 2014
PDF 49.9 KB Add to Briefcase
View Summary VIVUS Announces Date of Third Quarter 2014 Update and Financial Results Conference Call
Oct 30, 2014
PDF 9.4 KB Add to Briefcase
View Summary Newly Published Data Highlight the Effects of Weight Loss With Qsymia in Type 2 Diabetes
Oct 6, 2014
PDF 14.4 KB Add to Briefcase
View Summary VIVUS and Auxilium Announce FDA Approval of STENDRA sNDA; STENDRA Now First and Only Oral Erectile Dysfunction Treatment Approved to Be Taken Approximately 15 Minutes Before Sexual Activity
Sep 18, 2014
PDF 24.2 KB Add to Briefcase
View Summary VIVUS Announces Acquisition of Topiramate-Related Patents From Janssen Pharmaceuticals
Aug 25, 2014
PDF 12.0 KB Add to Briefcase
View Summary VIVUS Reports Second Quarter 2014 Financial Results
Aug 7, 2014
PDF 32.1 KB Add to Briefcase
View Summary VIVUS Announces Date of Second Quarter 2014 Update and Financial Results Conference Call
Jul 31, 2014
PDF 9.3 KB Add to Briefcase
View Summary VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents
Jun 12, 2014
PDF 11.7 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Jun 12, 2014
PDF 9.4 KB Add to Briefcase
View Summary Avanafil Clinical Data to Be Presented at American Urological Association
May 19, 2014
PDF 14.1 KB Add to Briefcase
View Summary VIVUS Announces Qsymia Presentation at the American Association of Clinical Endocrinologists (AACE)
May 15, 2014
PDF 11.6 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
May 8, 2014
PDF 9.4 KB Add to Briefcase
View Summary VIVUS Reports First Quarter 2014 Financial Results
May 5, 2014
PDF 30.0 KB Add to Briefcase
View Summary VIVUS Announces Date of First Quarter 2014 Update and Financial Results Conference Call
Apr 29, 2014
PDF 9.4 KB Add to Briefcase
View Summary Avanafil Clinical Data to Be Presented at European Association of Urology
Apr 11, 2014
PDF 14.0 KB Add to Briefcase
View Summary Three VIVUS Directors Not Standing for Re-Election
Apr 8, 2014
PDF 9.3 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Apr 3, 2014
PDF 9.3 KB Add to Briefcase
View Summary Newly Published Review Article Summarizes Cardiovascular Benefit-Risk Profile of Qsymia
Mar 25, 2014
PDF 13.2 KB Add to Briefcase
Showing 1-20 of 384 Page: 1 2 3 ... 20  Next 20
= add release to Briefcase